[HTML][HTML] Bifunctional Aptamer Drug Carrier Enabling Selective and Efficient Incorporation of an Approved Anticancer Drug Irinotecan to Fibrin Gels
H Fujita, Y Kataoka, M Kuwahara - Applied Sciences, 2020 - mdpi.com
We have previously developed a bifunctional aptamer (bApt) binding to both human
thrombin and camptothecin derivative (CPT1), and showed that bApt acts as a drug carrier …
thrombin and camptothecin derivative (CPT1), and showed that bApt acts as a drug carrier …
Bifunctional Aptamer Drug Carrier Enabling Selective and Efficient Incorporation of an Approved Anticancer Drug Irinotecan to Fibrin Gels
H Fujita, Y Kataoka, M Kuwahara - 2020 - agris.fao.org
We have previously developed a bifunctional aptamer (bApt) binding to both human
thrombin and camptothecin derivative (CPT1), and showed that bApt acts as a drug carrier …
thrombin and camptothecin derivative (CPT1), and showed that bApt acts as a drug carrier …
Bifunctional Aptamer Drug Carrier Enabling Selective and Efficient Incorporation of an Approved Anticancer Drug Irinotecan to Fibrin Gels
H Fujita, Y Kataoka, M Kuwahara - search.proquest.com
We have previously developed a bifunctional aptamer (bApt) binding to both human
thrombin and camptothecin derivative (CPT1), and showed that bApt acts as a drug carrier …
thrombin and camptothecin derivative (CPT1), and showed that bApt acts as a drug carrier …
Bifunctional Aptamer Drug Carrier Enabling Selective and Efficient Incorporation of an Approved Anticancer Drug Irinotecan to Fibrin Gels.
H Fujita, Y Kataoka… - Applied Sciences (2076 …, 2020 - search.ebscohost.com
We have previously developed a bifunctional aptamer (bApt) binding to both human
thrombin and camptothecin derivative (CPT1), and showed that bApt acts as a drug carrier …
thrombin and camptothecin derivative (CPT1), and showed that bApt acts as a drug carrier …